These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 32782381)

  • 1. RUNX1 mutations in blast-phase chronic myeloid leukemia associate with distinct phenotypes, transcriptional profiles, and drug responses.
    Adnan Awad S; Dufva O; Ianevski A; Ghimire B; Koski J; Maliniemi P; Thomson D; Schreiber A; Heckman CA; Koskenvesa P; Korhonen M; Porkka K; Branford S; Aittokallio T; Kankainen M; Mustjoki S
    Leukemia; 2021 Apr; 35(4):1087-1099. PubMed ID: 32782381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RUNX1 DNA-binding mutations and RUNX1-PRDM16 cryptic fusions in BCR-ABL+ leukemias are frequently associated with secondary trisomy 21 and may contribute to clonal evolution and imatinib resistance.
    Roche-Lestienne C; Deluche L; Corm S; Tigaud I; Joha S; Philippe N; Geffroy S; Laï JL; Nicolini FE; Preudhomme C;
    Blood; 2008 Apr; 111(7):3735-41. PubMed ID: 18202228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytogenetic landscape and impact in blast phase of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy.
    Chen Z; Shao C; Wang W; Zuo Z; Mou X; Hu SJ; DiGiuseppe JA; Zu Y; Medeiros LJ; Hu S
    Leukemia; 2017 Mar; 31(3):585-592. PubMed ID: 27560111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A deep-sequencing study of chronic myeloid leukemia patients in blast crisis (BC-CML) detects mutations in 76.9% of cases.
    Grossmann V; Kohlmann A; Zenger M; Schindela S; Eder C; Weissmann S; Schnittger S; Kern W; Müller MC; Hochhaus A; Haferlach T; Haferlach C
    Leukemia; 2011 Mar; 25(3):557-60. PubMed ID: 21274004
    [No Abstract]   [Full Text] [Related]  

  • 5. IKZF1 deletion and co-occurrence with other aberrations in a child with chronic myeloid leukemia progressing to acute lymphoblastic leukemia.
    Klumb CE; Barbosa TDC; Nestal de Moraes G; Schramm MT; Emerenciano M; Maia RC
    Pediatr Blood Cancer; 2019 Apr; 66(4):e27570. PubMed ID: 30511400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional features of RUNX1 mutants in acute transformation of chronic myeloid leukemia and their contribution to inducing murine full-blown leukemia.
    Zhao LJ; Wang YY; Li G; Ma LY; Xiong SM; Weng XQ; Zhang WN; Wu B; Chen Z; Chen SJ
    Blood; 2012 Mar; 119(12):2873-82. PubMed ID: 22318203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation and refinement of a RUNX1 mutation-associated gene expression signature in blast crisis chronic myeloid leukemia.
    Lee KL; Ko TK; Saw NYL; Javed A; Hillmer AM; Chuah C; Krishnan V; Ong ST
    Leukemia; 2022 Mar; 36(3):892-896. PubMed ID: 35121847
    [No Abstract]   [Full Text] [Related]  

  • 8. Combined inhibition of β-catenin and Bcr-Abl synergistically targets tyrosine kinase inhibitor-resistant blast crisis chronic myeloid leukemia blasts and progenitors in vitro and in vivo.
    Zhou H; Mak PY; Mu H; Mak DH; Zeng Z; Cortes J; Liu Q; Andreeff M; Carter BZ
    Leukemia; 2017 Oct; 31(10):2065-2074. PubMed ID: 28321124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of the TCR Vβ repertoire in imatinib-resistant chronic myeloid leukemia patients with ABL mutations.
    Xu L; Lu Y; Lai J; Yu W; Zhang Y; Jin Z; Xu Y; Chen J; Zha X; Chen S; Yang L; Li Y
    Sci China Life Sci; 2015 Dec; 58(12):1276-81. PubMed ID: 26423566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonal evolution of AML1-ETO coexisting with BCR-ABL and additional chromosome abnormalities in a blastic transformation of chronic myeloid leukemia.
    Ma CC; Chai Y; Chen HL; Wang X; Gao Y; Hu WL; Xiang X
    J Int Med Res; 2020 May; 48(5):300060520919237. PubMed ID: 32366154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal evolution and clinical implications of genetic abnormalities in blastic transformation of chronic myeloid leukaemia.
    Ochi Y; Yoshida K; Huang YJ; Kuo MC; Nannya Y; Sasaki K; Mitani K; Hosoya N; Hiramoto N; Ishikawa T; Branford S; Shanmuganathan N; Ohyashiki K; Takahashi N; Takaku T; Tsuchiya S; Kanemura N; Nakamura N; Ueda Y; Yoshihara S; Bera R; Shiozawa Y; Zhao L; Takeda J; Watatani Y; Okuda R; Makishima H; Shiraishi Y; Chiba K; Tanaka H; Sanada M; Takaori-Kondo A; Miyano S; Ogawa S; Shih LY
    Nat Commun; 2021 May; 12(1):2833. PubMed ID: 33990592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryptic and partial deletions of PRDM16 and RUNX1 without t(1;21)(p36;q22) and/or RUNX1-PRDM16 fusion in a case of progressive chronic myeloid leukemia: a complex chromosomal rearrangement of underestimated frequency in disease progression?
    Deluche L; Joha S; Corm S; Daudignon A; Geffroy S; Quief S; Villenet C; Kerckaert JP; Laï JL; Preudhomme C; Roche-Lestienne C
    Genes Chromosomes Cancer; 2008 Dec; 47(12):1110-7. PubMed ID: 18767145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-cell transcriptomics uncovers distinct molecular signatures of stem cells in chronic myeloid leukemia.
    Giustacchini A; Thongjuea S; Barkas N; Woll PS; Povinelli BJ; Booth CAG; Sopp P; Norfo R; Rodriguez-Meira A; Ashley N; Jamieson L; Vyas P; Anderson K; Segerstolpe Å; Qian H; Olsson-Strömberg U; Mustjoki S; Sandberg R; Jacobsen SEW; Mead AJ
    Nat Med; 2017 Jun; 23(6):692-702. PubMed ID: 28504724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant RAG-mediated recombination contributes to multiple structural rearrangements in lymphoid blast crisis of chronic myeloid leukemia.
    Thomson DW; Shahrin NH; Wang PPS; Wadham C; Shanmuganathan N; Scott HS; Dinger ME; Hughes TP; Schreiber AW; Branford S
    Leukemia; 2020 Aug; 34(8):2051-2063. PubMed ID: 32076119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic Myeloid Leukemia with cryptic Philadelphia translocation and extramedullary B-lymphoid blast phase as an initial presentation.
    Soliman DS; Amer AM; Mudawi D; Al-Sabbagh Z; Alkuwari E; Al-Sabbagh A; Ibrahim F; Yassin MA
    Acta Biomed; 2018 Apr; 89(3-S):38-44. PubMed ID: 29633732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic myeloid leukemia with pure erythroid leukemia blast crisis.
    Jacobs JW; Ramaswamy R; States V; Reppucci J; Oluwole OO; Mason EF; Thompson MA
    Leuk Lymphoma; 2022 Jan; 63(1):212-216. PubMed ID: 34486918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole exome sequencing identifies a novel FANCD2 gene splice site mutation associated with disease progression in chronic myeloid leukemia: Implication in targeted therapy of advanced phase CML.
    Absar M; Mahmood A; Akhtar T; Basit S; Ramzan K; Jameel A; Afzal S; Ullah A; Qureshi K; Alanazi N; Iqbal Z
    Pak J Pharm Sci; 2020 May; 33(3(Special)):1419-1426. PubMed ID: 33361032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors and survival outcomes in patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era: Cohort study of 477 patients.
    Jain P; Kantarjian HM; Ghorab A; Sasaki K; Jabbour EJ; Nogueras Gonzalez G; Kanagal-Shamanna R; Issa GC; Garcia-Manero G; Kc D; Dellasala S; Pierce S; Konopleva M; Wierda WG; Verstovsek S; Daver NG; Kadia TM; Borthakur G; O'Brien S; Estrov Z; Ravandi F; Cortes JE
    Cancer; 2017 Nov; 123(22):4391-4402. PubMed ID: 28743165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletions of immunoglobulin heavy chain and T cell receptor gene regions are uniquely associated with lymphoid blast transformation of chronic myeloid leukemia.
    Nacheva EP; Brazma D; Virgili A; Howard-Reeves J; Chanalaris A; Gancheva K; Apostolova M; Valgañon M; Mazzullo H; Grace C
    BMC Genomics; 2010 Jan; 11():41. PubMed ID: 20082691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Research advance on molecular genetics of CML blast crisis].
    Zhu HQ; Zhang S; Liu XL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):217-21. PubMed ID: 18315935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.